NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline PTGX Q1 2026 Earnings Surprise Profitability Defies Estimates Amid No Revenue TIPT Q2 2025 Earnings EPS of 058 Reported Amid Modest Stock Decline JOUT Q1 2026 Earnings Earnings Beat Amidst Challenging Outdoor Market Conditions XYL Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick SLM Q1 2026 Earnings EPS Surges Past Estimates by 356 Stock Slips